News Chengdu Olymvax Biopharmaceuticals Inc.

Equities

688319

CNE1000051H8

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
8.11 ^CNY	-4.70%		-5.26%	-48.67%

May. 16	Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials	MT
Apr. 25	Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials	May. 16	MT
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Olymvax Biopharmaceuticals Withdraws Application for Combined Influenza Vaccine	Feb. 02	MT
Olymvax Biopharmaceuticals Grants Keyuan Xinhai Marketing Rights for Meningococcal Vaccines	Dec. 12	MT
Olymvax Biopharmaceuticals to Push Through Phase III Trial Into Recombinant Staphylococcus Aureus Vaccine	Nov. 21	MT
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Chengdu Olymvax Biopharmaceuticals Inc.(XSSC:688319) added to S&P Global BMI Index	23-09-18	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Chinese healthcare stocks hit by stepped up anti-graft crackdown	23-08-09	RE
Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine	23-07-12	MT
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-17	CI
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange A Share Index	22-06-08	CI
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange Composite Index	22-06-08	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22	CI
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chengdu Olymvax Biopharmaceuticals Inc.

Equities

688319

CNE1000051H8

Summary

Filters